SC 13D/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
(RULE 13D - 101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND
AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)

(Amendment No. 4)*

Sonida Senior Living, Inc.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)
140475203

(CUSIP Number)

Paul Dumaine

Conversant Capital LLC

25 Deforest Avenue

Summit, NJ 07901

908-466-5100

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

With a copy to:

John M. Bibona

Fried, Frank, Harris, Shriver & Jacobson LLP

One New York Plaza

New York, NY 10004

(212) 859-8000

March 22, 2024

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Note

1	NAMES OF REPORTING PERSONS
	Conversant Dallas Parkway (A) LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☒
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			0
		8	SHARED VOTING POWER
			7,455,182 (1)
		9	SOLE DISPOSITIVE POWER
			0
		10	SHARED DISPOSITIVE POWER
			7,455,182 (1)
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	7,455,182 (1)
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	47.2% (2)
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

(1) Consists of (i) 5,031,801 shares of Common Stock, (ii) 1,139,759 shares of Common Stock issuable upon conversion of 38,742 shares of Series A Preferred Stock of the Issuer, (iii) 968,538 shares of Common Stock issuable upon exercise of warrants of the Issuer, and (iv) 315,084 shares of Common Stock issuable upon draws by the Issuer under the Conversant Equity Commitment.

(2) The percentage reflected is based on the sum of (i) 11,528,724 outstanding shares of Common Stock on February 12, 2024, as provided under Schedule 14-A filed by the Issuer with the Commission on February 20, 2024, plus (ii) 1,213,542 shares of Common Stock issuable in the aggregate upon conversion of the Series A Preferred Stock held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iv) 350,000 shares of Common Stock issuable in the aggregate upon draws of the Issuer under the Conversant Equity Commitment entered into by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (v) 1,675,440 shares of Common Stock issued pursuant to the Private Placement (as defined below).

1	NAMES OF REPORTING PERSONS
	Conversant Dallas Parkway (B) LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☒
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			0
		8	SHARED VOTING POWER
			1,318,270 (1)
		9	SOLE DISPOSITIVE POWER
			0
		10	SHARED DISPOSITIVE POWER
			1,318,270 (1)
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,318,270 (1)
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	8.3% (2)
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

(1) Consists of (i) 1,146,859 shares of Common Stock, (ii) 73,783 shares of Common Stock issuable upon conversion of 2,508 shares of Series A Preferred Stock of the Issuer, (iii) 62,712 shares of Common Stock issuable upon exercise of warrants of the Issuer, and (iv) 34,916 shares of Common Stock issuable upon draws by the Issuer under the Conversant Equity Commitment.

(2) The percentage reflected is based on the sum of (i) 11,528,724 outstanding shares of Common Stock on February 12, 2024, as provided under Schedule 14-A filed by the Issuer with the Commission on February 20, 2024, plus (ii) 1,213,542 shares of Common Stock issuable in the aggregate upon conversion of the Series A Preferred Stock held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iv) 350,000 shares of Common Stock issuable in the aggregate upon draws of the Issuer under the Conversant Equity Commitment entered into by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (v) 1,675,440 shares of Common Stock issued pursuant to the Private Placement (as defined below).

1	NAMES OF REPORTING PERSONS
	Conversant Dallas Parkway (D) LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☒
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			0
		8	SHARED VOTING POWER
			1,032,216 (1)
		9	SOLE DISPOSITIVE POWER
			0
		10	SHARED DISPOSITIVE POWER
			1,032,216 (1)
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,032,216 (1)
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	6.5% (2)
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

(1) Consists of 1,032,216 shares of Common Stock.

(2) The percentage reflected is based on the sum of (i) 11,528,724 outstanding shares of Common Stock on February 12, 2024, as provided under Schedule 14-A filed by the Issuer with the Commission on February 20, 2024, plus (ii) 1,213,542 shares of Common Stock issuable in the aggregate upon conversion of the Series A Preferred Stock held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iv) 350,000 shares of Common Stock issuable in the aggregate upon draws of the Issuer under the Conversant Equity Commitment entered into by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (v) 1,675,440 shares of Common Stock issued pursuant to the Private Placement (as defined below).

1	NAMES OF REPORTING PERSONS
	Conversant GP Holdings LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☐
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			0
		8	SHARED VOTING POWER
			9,805,668 (1)
		9	SOLE DISPOSITIVE POWER
			0
		10	SHARED DISPOSITIVE POWER
			9,805,668 (1)
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	9,805,668 (1)
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	62.1% (2)
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

 

(1) Consists of (i) 7,210,876 shares of Common Stock, (ii) 1,213,542 shares of Common Stock issuable upon conversion of 41,250 shares of Series A Preferred Stock of the Issuer, (iii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer, and (iv) 350,000 shares of Common Stock issuable upon draws by the Issuer under the Conversant Equity Commitment.

(2) The percentage reflected is based on the sum of (i) 11,528,724 outstanding shares of Common Stock on February 12, 2024, as provided under Schedule 14-A filed by the Issuer with the Commission on February 20, 2024, plus (ii) 1,213,542 shares of Common Stock issuable in the aggregate upon conversion of the Series A Preferred Stock held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iv) 350,000 shares of Common Stock issuable in the aggregate upon draws of the Issuer under the Conversant Equity Commitment entered into by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (v) 1,675,440 shares of Common Stock issued pursuant to the Private Placement (as defined below).

1	NAMES OF REPORTING PERSONS
	Michael J. Simanovsky
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☐
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			0
		8	SHARED VOTING POWER
			9,805,668 (1)
		9	SOLE DISPOSITIVE POWER
			0
		10	SHARED DISPOSITIVE POWER
			9,805,668 (1)
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	9,805,668 (1)
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	62.1% (2)
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN

(1) Consists of (i) 7,210,876 shares of Common Stock, (ii) 1,213,542 shares of Common Stock issuable upon conversion of 41,250 shares of Series A Preferred Stock of the Issuer, (iii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer, and (iv) 350,000 shares of Common Stock issuable upon draws by the Issuer under the Conversant Equity Commitment.

(2) The percentage reflected is based on the sum of (i) 11,528,724 outstanding shares of Common Stock on February 12, 2024, as provided under Schedule 14-A filed by the Issuer with the Commission on February 20, 2024, plus (ii) 1,213,542 shares of Common Stock issuable in the aggregate upon conversion of the Series A Preferred Stock held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iv) 350,000 shares of Common Stock issuable in the aggregate upon draws of the Issuer under the Conversant Equity Commitment entered into by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (v) 1,675,440 shares of Common Stock issued pursuant to the Private Placement (as defined below).

1	NAMES OF REPORTING PERSONS
	Conversant Capital LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)	☐
				(b)	☒
3	SEC USE ONLY
4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			0
		8	SHARED VOTING POWER
			9,805,668 (1)
		9	SOLE DISPOSITIVE POWER
			0
		10	SHARED DISPOSITIVE POWER
			9,805,668 (1)
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	9,805,668 (1)
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)				☐
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	62.1% (2)
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO, IA

(1) Consists of (i) 7,210,876shares of Common Stock, (ii) 1,213,542 shares of Common Stock issuable upon conversion of 41,250 shares of Series A Preferred Stock of the Issuer, (iii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer, and (iv) 350,000 shares of Common Stock issuable upon draws by the Issuer under the Conversant Equity Commitment.

(2) The percentage reflected is based on the sum of (i) 11,528,724 outstanding shares of Common Stock on February 12, 2024, as provided under Schedule 14-A filed by the Issuer with the Commission on February 20, 2024, plus (ii) 1,213,542 shares of Common Stock issuable in the aggregate upon conversion of the Series A Preferred Stock held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (iv) 350,000 shares of Common Stock issuable in the aggregate upon draws of the Issuer under the Conversant Equity Commitment entered into by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP, plus (v) 1,675,440 shares of Common Stock issued pursuant to the Private Placement (as defined below).

This Amendment No. 4 (“Amendment No. 4”) further amends and supplements the original statement on Schedule 13D filed by Conversant Dallas Parkway (A), L.P. (“Investor A”), Conversant Dallas Parkway (B), L.P. (“Investor B”), Conversant GP Holdings LLC (“Conversant GP), Conversant Capital LLC (“Conversant Capital”), and Michael J. Simanovsky on November 12, 2021 (the “Original Schedule 13D”), as previously amended by them by the amended statement on Schedule 13D filed on February 6, 2024 (“Amendment No. 3”), Amendment No. 2 filed on November 6, 2023 (“Amendment No. 2”) and Amendment No. 1 filed on July 7, 2023 (“Amendment No. 1”). To the extent applicable, the Original Schedule 13D, as previously and hereby amended, is hereby adopted by Conversant Dallas Parkway (D), L.P. (“Investor D”) as its original filing on Schedule 13D regarding the Issuer. Investor D, Investor A and Investor B together are the “Conversant Investors,” and they, together with Conversant GP, Conversant Capital and Mr. Simanovsky are, the “Reporting Persons.” The Original Schedule 13D, as previously amended, remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 4, provided that with respect to any Item amended herein, if such Item is incorporated by reference into any other Item in the Original Schedule 13D, as previously amended, such incorporation by reference is also amended hereby. Capitalized terms used and not defined in this Amendment No. 4 have the meanings set forth in the Original Schedule 13D, as previously amended.

Item 2.      Identity and Background.

Item 2 is hereby amended and restated to read as follows:

(a), (f) This Schedule 13D is being filed pursuant to Rule 13d-1(a) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), by:

i.	Conversant Dallas Parkway (A), L.P., a Delaware limited partnership (“Investor A”);
ii.	Conversant Dallas Parkway (B), L.P., a Delaware limited partnership (“Investor B”);
iii.	Conversant Dallas Parkway (D), L.P., a Delaware limited partnership (“Investor D” and together with Investor A and Investor B, the “Conversant Investors”)
iii.	Conversant GP Holdings LLC, a Delaware limited liability company (“Conversant GP”);
iv.	Michael J. Simanovsky, a citizen of the United States of America; and
v.	Conversant Capital LLC, a Delaware limited liability company (“Conversant Capital” and together with the Conversant Investors, Conversant GP, and Mr. Simanovsky, the “Reporting Persons”).

The Conversant Investors are alternative investment vehicles of Conversant GP; established for purpose of investing in Issuer’s securities. Conversant Capital is the investment manager of and makes investment decisions for the Conversant Investors. Mr. Simanovsky is the managing member of Conversant Capital. Conversant GP is the general partner of each of the Conversant Investors. Mr. Simanovsky is the managing member of Conversant GP. By virtue of these relationships, each of Conversant Capital, Conversant GP, and Mr. Simanovsky may be deemed to beneficially own the shares of Common Stock (including Common stock issuable upon conversion of Series A Preferred Stock or upon exercise of warrants to purchase Common Stock) owned directly by the Conversant Investors.

The Reporting Persons are filing this statement jointly with respect to the same securities as contemplated by Rule 13d-1(k)(1). The Conversant Investors and Conversant Capital may constitute a “group” within the meaning of Section 13(d)(3) of the Exchange Act and Rule 13d-5(b) promulgated by the Securities and Exchange Commission (the “Commission”) thereunder. Each of the Conversant Investors expressly disclaims beneficial ownership of the shares of Common Stock owned and held by the other Reporting Persons.

(b) The address of the principal business office of each of the Reporting Persons is: c/o Conversant Capital LLC, 25 Deforest Avenue, Summit, NJ 07901.

(c) The principal business of Mr. Simanovsky is investment management. Investor A, Investor B and Investor D are each private investment vehicles. Conversant GP is the general partner of the Conversant Investors and Conversant Capital is the investment manager to the Conversant Investors.

(d)-(e) During the last five years, none of the Reporting Persons have: (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 3.      Source and Amount of Funds or Other Consideration.

Item 3 is hereby amended by the addition of the following:

The disclosure set forth in Item 4 below of this Amendment regarding the acquisition shares of Common Stock in the second closing of the Private Placement is incorporated herein.

Item 4.      Purpose of Transaction.

Item 4 is hereby amended by the addition of the following:

As disclosed on the Issuer Private Placement 8-K, the Conversant Investors, along with other investors, entered into the Securities Purchase Agreement with the Issuer pursuant to a Private Placement in which Investor A agreed to purchase 1,892,457 shares of Common Stock and Investor B agreed to purchase 1,265,438 shares of Common Stock at a price of $9.50 per share. At the first closing of the Private Placement, completed on February 1, 2024, the Company issued and sold 1,261,638 shares of Common Stock to Investor A and 843,625 shares of Common Stock to Investor B.

On March 21, 2024, the Conversant Investors entered into a Partial Assignment and Assumption of Securities Purchase Agreement pursuant to which each of Investor A and Investor B assigned to Investor D a portion of their rights and interests to purchase shares of Common Stock in the second closing of the Private Placement as provided therein, as well as the obligations under the Securities Purchase Agreement. On the same date, Investor D entered into a Joinder Agreement to the Securities Purchase Agreement with the Issuer.

At the second closing, completed on March 22, 2024, the Company issued the remaining 5,227 shares of Common Stock to Investor A, 15,189 shares of Common Stock to Investor B and 1,032,216 shares of Common Stock to Investor D, along with additional shares to the other participating purchasers. The Conversant Investors paid for the shares of Common Stock acquired in the second closing of the Private Placement using a combination of their existing investment capital and by calling capital from its investors. The second closing was subject, among other, to the Stockholder Approval, which occurred on March 21, 2024.

Item 5.      Interest in Securities of the Issuer.

Items 5(a) and (b) are hereby amended and restated to read as follows:

(a) (b) For information regarding beneficial ownership, see the information presented on the cover pages of this Schedule 13D.

Item 5(c) is hereby amended and restated to read as follows:

(c) The disclosure set forth above in Item 4 of this Amendment regarding the acquisition of the shares of Common Stock in the second closing of the Private Placement is incorporated herein.

Item 6.      Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Item 6 is hereby amended by the addition of the following:

The disclosure set forth in Item 4 above of this Amendment regarding the assignment of rights to purchase Common Stock to Investor D and the acquisition shares of Common Stock in the second closing of the Private Placement is incorporated herein.

Item 7.       Material to be Filed as Exhibits

Item 7 is hereby amended by the addition of Exhibits 1.7 and 1.8 and the replacement of Exhibit 99.1.

1.7	Partial Assignment and Assumption of Securities Purchase Agreement, dated March 21, 2024.
1.8	Joinder Agreement to Securities Purchase Agreement, dated March 21, 2024.
99.1	Joint Filing Agreement.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: March 26, 2024

CONVERSANT DALLAS PARKWAY (A) LP

By:  Conversant GP Holdings LLC, its general partner

/s/ Paul Dumaine

Name: Paul Dumaine

Title:  General Counsel and Chief Compliance Officer

CONVERSANT DALLAS PARKWAY (B) LP

By:  Conversant GP Holdings LLC, its general partner

/s/ Paul Dumaine

Name: Paul Dumaine

Title:  General Counsel and Chief Compliance Officer

CONVERSANT DALLAS PARKWAY (D) LP

By:  Conversant GP Holdings LLC, its general partner

/s/ Paul Dumaine

Name:  Paul Dumaine

Title:  General Counsel and Chief Compliance Officer

CONVERSANT GP HOLDINGS LLC

/s/ Paul Dumaine

Name: Paul Dumaine

Title: General Counsel and Chief Compliance Officer

CONVERSANT CAPITAL LLC

/s/ Paul Dumaine

Name: Paul Dumaine

Title: General Counsel and Chief Compliance Officer

MICHAEL SIMANOVSKY

/s/ Paul Dumaine

Name: Paul Dumaine

Title:  Attorney-in-fact for Michael J. Simanovsky

 

EX-1.7

Exhibit 1.7

PARTIAL ASSIGNMENT AND ASSUMPTION OF
SECURITIES PURCHASE AGREEMENT

This PARTIAL ASSIGNMENT AND ASSUMPTION OF SECURITIES PURCHASE AGREEMENT (this “Assignment Agreement”) is entered into as of March 21, 2024, by and among Conversant Dallas Parkway (A) LP, a Delaware limited Partnership (“Conversant A”), Conversant Dallas Parkway (B) LP, a Delaware limited Partnership (“Conversant B”, and together with Conversant A, collectively, the “Assignors” and each an “Assignor”), and Conversant Dallas Parkway (D) LP, a Delaware limited Partnership (“Assignee”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in that certain Securities Purchase Agreement, dated as of February 1, 2024 (as it may be amended in accordance with its terms, the “Securities Purchase Agreement”), by and among Sonida Senior Living Inc., a Delaware corporation (“Seller”) and each of the purchasers, severally and not jointly, listed on Annex A thereto, including the Assignors (collectively, the “Purchasers”).

WHEREAS, the Company agreed to sell and issue to the several Purchasers on the Second Closing Date, pursuant to the Private Placement, the number of shares of Common Stock, set forth opposite such Purchaser’s name on Annex A to the Securities Purchase Agreement under the heading “Second Closing,” at a purchase price of $9.50 per share (the “Second Closing Schedule”);

WHEREAS, pursuant to the Second Closing Schedule, Conversant A agreed to purchase 630,819 shares of Common Stock of the Company for an aggregate purchase price of $5,992,780.50 and Conversant B agreed to purchase 421,813 shares of Common Stock of the Company for an aggregate purchase price of $4,007,223.50;

WHEREAS, the Assignors wish to transfer and assign to the Assignee a portion of the Assignors’ rights and interests in and to, and obligations under, the Securities Purchase Agreement, with respect to the purchase of shares of Common Stock on the Second Closing Date such that the shares previously allocated to Assignors are allocated to the Assignors and the Assignee as set forth on Schedule I hereto (the “Assigned Second Closing Stock”), and the Assignee wishes to be the assignee and transferee of such rights, interests and obligations with respect to the Assigned Second Closing Stock under the Securities Purchase Agreement;

WHEREAS, pursuant to Section 7.4 of the Securities Purchase Agreement, the Assignors may assign any of their rights, interests or obligations under the Securities Purchase Agreement, in whole or in part to any Permitted Transferee; and

WHEREAS, the Assignee is a Permitted Transferee of the Assignors.

NOW, THEREFORE, the parties hereto, intending to be legally bound, do hereby agree as follows:

1.Assignment and Assumption. The Assignors hereby transfer and assign to the Assignee, and the Assignee hereby acquires from the Assignors all of the Assignors’ rights, and interests in and to the Assigned Second Closing Stock, of whatever kind or nature, and the Assignee hereby assumes and agrees to perform all obligations, duties, liabilities and commitments of the Assignors under the Stock Purchase Agreement with respect to the Assigned Second Closing Stock, of whatever kind or nature.

2.Retention of Obligations. Notwithstanding anything in this Assignment Agreement to the contrary, the Assignors shall remain obligated to Seller with respect to all of the Assignors’ obligations, duties, liabilities and commitments under the Securities Purchase Agreement, of whatever kind or nature that have not been specifically assigned hereunder.

3.Effectiveness. This Assignment Agreement shall be effective as of the date set first set forth above.

4.Governing Law; Binding Effect. This Assignment Agreement and any disputes arising out of or relating to this Assignment Agreement and the transactions contemplated hereby (whether in contract, tort, or otherwise) will be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any conflict or choice of law principles of the State of Delaware or otherwise that would result in the application of any laws other than the laws of the State of Delaware.

5.Counterparts. This Assignment Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument. Counterparts may be delivered via electronic mail (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

[Signature Pages Follow]

IN WITNESS WHEREOF, the Assignee and the Assignors have executed this Assignment Agreement as of the date first set forth above.

ASSIGNORS:

CONVERSANT DALLAS PARKWAY (A) LP

By: Conversant GP Holdings, LLC, its general partner

By: /s/ Paul Dumaine          

Name: Paul Dumaine

Title: General Counsel

CONVERSANT DALLAS PARKWAY (B) LP

By: Conversant GP Holdings, LLC, its general partner

By: /s/ Paul Dumaine          

Name: Paul Dumaine

Title: General Counsel

ASSIGNEE:

CONVERSANT DALLAS PARKWAY (D) LP

By: Conversant GP Holdings, LLC, its general partner

By: /s/ Paul Dumaine         

Name: Paul Dumaine

Title: General Counsel

Schedule I

Second Closing Number of Shares and Aggregate Purchase Price

Purchaser Name	Number of Second Closing Shares	Aggregate Purchase Price
Conversant Dallas Parkway (A) LP	5,227	$49,656.50
Conversant Dallas Parkway (B) LP	15,189	$144,295.50
Conversant Dallas Parkway (D) LP	1,032,216	$9,806,052.00
Total	1.052,632	$10,000,004.00

EX-1.8

Exhibit 1.8

JOINDER AGREEMENT TO SECURITIES PURCHASE AGREEMENT

March 21, 2024

Reference is made to that certain Securities Purchase Agreement, dated as of February 1, 2024 (the “SPA”), by and among Sonida Senior Living, Inc., a Delaware corporation (the “Company”), and each of the purchasers, severally and not jointly, listed on Annex A thereto (collectively, the “Purchasers”). All capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the SPA.

WHEREAS, on February 1, 2024, the First Closing occurred, and the Company issued an aggregate of 3,350,878 First Closing Shares of Common Stock to the Purchasers at a purchase price of $9.50 per share;

WHEREAS, the SPA provides that each of the Purchasers may assign their respective commitment to purchase the Second Closing Shares under the SPA in whole or in part to any Permitted Transferee subject to such Permitted Transferee making the representations and warranties set forth in Section 2.2 of the SPA, and each such Permitted Transferee will be entitled to the full benefit and be subject to the obligations of the SPA as if such Person were a “Purchaser” thereunder;

WHEREAS, Conversant Dallas Parkway (A) LP (“Conversant A”) and Conversant Dallas Parkway (B) LP (“Conversant B” and, together with Conversant A, “Conversant”) each desire to assign a portion of their respective commitment to purchase the Second Closing Shares to Conversant Dallas Parkway (D) LP (the “New Purchaser”), a Permitted Transferee of Conversant;

WHEREAS, immediately following such assignment and for purposes of the Second Closing, the Second Closing Shares that the Company will issue and sell to Conversant and the New Purchaser, and that Conversant and the New Purchaser will purchase from the Company, are set forth in Schedule I hereto; and

WHEREAS, New Purchaser is entering into this Joinder Agreement for purposes of, among other, making the representations and warranties set forth in Section 2.2 of the SPA to the Company and confirming that New Purchaser will be entitled to the full benefit and be subject to the obligations of the SPA as if New Purchaser were a “Purchaser” thereunder.

NOW THEREFORE, for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties agree as follows:

1.Agreement to be Bound. New Purchaser acknowledges and agrees that, upon the execution of this Joinder Agreement, New Purchaser shall join and become a party to the SPA as a “Purchaser” under the SPA and shall be fully bound by, and subject to, all of the covenants, terms and conditions, and warranties as though an original party thereto, including, without limitation, the obligation to purchase the Second Closing Shares set forth opposite its name in Schedule I hereto, subject to the terms and conditions of the SPA.

2.SPA Representations and Warranties. New Purchaser hereby makes and confirms the representations and warranties in Section 2.2 of the SPA as a “Purchaser” with respect solely to itself and not with respect to any other Purchaser, with same force and effect as if such representations and warranties were set forth herein in in their entirety for the express benefit and reliance of the Company.

3.Joinder Agreement Representations and Warranties. New Purchaser hereby further represents and warrants to the Company that (i) it has the full right, power and authority to enter into this Joinder Agreement, and (ii) the execution of this Joinder Agreement by the individual whose signature is set forth at the end of this Joinder Agreement on behalf of New Purchaser, and the delivery of this Joinder Agreement by New Purchaser, have been duly authorized by all necessary action on the part of New Purchaser; (iii) this Joinder Agreement has been executed and delivered by New Purchaser and constitutes the legal, valid and binding obligation of New Purchaser, enforceable against such party in accordance with its terms, except as may be limited by any applicable bankruptcy,  insolvency, reorganization, moratorium, or similar laws and equitable principles related to or affecting creditors’ rights generally or the effect of general principles of equity; (iv) New Purchaser is a Permitted Transferee of Conversant; and (v) New Purchaser has carefully and completely read this Joinder Agreement as well as the SPA and fully and completely understands, accepts, and is satisfied with the terms and conditions of this Joinder Agreement and the SPA.

4.Governing Law. This Agreement and any disputes arising out of or relating to this Agreement and the transactions contemplated hereby (whether in contract, tort, or otherwise) will be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any conflict or choice of law principles of the State of Delaware or otherwise that would result in the application of any laws other than the laws of the State of Delaware.

5.Counterparts and Electronic Signature Pages. This Joinder Agreement may be executed in any number of counterparts, each of which when so executed and delivered will be an original, but such counterparts shall constitute one and the same instrument. Any electronic signature page to this Joinder Agreement shall be treated for all purposes as an original, manually- signed, signature page hereto.

[Signature Pages Follow]

IN WITNESS WHEREOF, the parties hereto have executed this Joinder Agreement as of the day and year first above written.

COMPANY:

SONIDA SENIOR LIVING, INC.

By: /s/ Brandon M. Ribar          

Name: Brandon M. Ribar

Title:  Chief Executive Officer and President

NEW PURCHASER:

CONVERSANT DALLAS PARKWAY (D) LP

By: Conversant GP Holdings, LLC, its general partner

By: /s/ Paul Dumaine

Name: Paul Dumaine

Title:  General Counsel

Address for Notice:

Conversant Dallas Parkway (D) LP

c/o Conversant Capital LLC

25 Deforest Avenue

Summit, New Jersey 07901

Attention:  Bryant Daniels

Email: bdaniels@conversantcap.com

With a copy to:

Conversant Dallas Parkway (D) LP

c/o Conversant Capital LLC

25 Deforest Avenue

Summit, New Jersey 07901

Attention:  General Counsel

Email: pdumaine@conversantcap.com

Schedule I

Second Closing Shares for Conversant and the New Purchaser

Purchaser Name	Number of Second Closing Shares	Aggregate Purchase Price
Conversant Dallas Parkway (A) LP	5,227	$49,656.50
Conversant Dallas Parkway (B) LP	15,189	$144,295.50
Conversant Dallas Parkway (D) LP	1,032,216	$9,806,052.00
Total	1,052,632	$10,000,004.00

EX-99.1

Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock and Preferred Stock of Sonida Senior Living, Inc., and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this agreement expressly authorizes each other party of this agreement to file on its behalf any and all amendments to such Statement on Schedule 13D.

Dated: March 26, 2024.

CONVERSANT DALLAS PARKWAY (A) LP

By:  Conversant GP Holdings LLC, its general partner

/s/ Paul Dumaine

Name: Paul Dumaine

Title:  General Counsel and Chief Compliance Officer

CONVERSANT DALLAS PARKWAY (B) LP

By:  Conversant GP Holdings LLC, its general partner

/s/ Paul Dumaine

Name: Paul Dumaine

Title:  General Counsel and Chief Compliance Officer

CONVERSANT DALLAS PARKWAY (D) LP

By:  Conversant GP Holdings LLC, its general partner

/s/ Paul Dumaine

Name:  Paul Dumaine

Title:  General Counsel and Chief Compliance Officer

CONVERSANT GP HOLDINGS LLC

/s/ Paul Dumaine

Name: Paul Dumaine

Title: General Counsel and Chief Compliance Officer

CONVERSANT CAPITAL LLC

/s/ Paul Dumaine

Name: Paul Dumaine

Title: General Counsel and Chief Compliance Officer

MICHAEL SIMANOVSKY

/s/ Paul Dumaine

Name: Paul Dumaine

Title:  Attorney-in-fact for Michael J. Simanovsky